Vance Just Cut $1.3 Billion to California Over Medicaid Fraud.
Hawaii Has Zero Indictments. NY Has Nine. The Audits Are Starting.

California — Newsom (D-CA): $1.3 billion in federal Medicaid reimbursements deferred. The deferment is administrative under CMS’s authority to withhold federal financial participation pending a fraud investigation. California operates one of the largest Medicaid programs in the country (Medi-Cal) and produces a high absolute number of indictments — but Vance’s framing is that the indictment density is far too low for the program’s size.

New York — Hochul (D-NY): 9 indictments over the last year on a $100 billion Medicaid program.The federal-share funding to New York’s MFCU is the largest single state allocation in the federal MFCU budget; the indictment-to-spend ratio Vance highlighted is one of the lowest in the federal data set.

Hawaii — Green (D-HI): Zero indictments. Zero convictions. Years.Hawaii’s Medicaid Fraud Control Unit, per Vance citing HHS-OIG’s annual statistical report, has not produced a single fraud indictment or conviction in years. The federal program does not have a statutory minimum case-count, but it does have an “effective performance” eligibility requirement that the federal audit is now interrogating.

Minnesota — Walz (D-MN) — the predicate: Earlier in 2026, the administration deferred more than $350 million in federal Medicaid reimbursements to Minnesota following the same kind of fraud findings — covered in Civic Intelligence’s prior reporting on the Walz-era SNAP / Medicaid pattern. The May 13 California action is the second, larger step in the same sequence.

The structure: Every state participating in Medicaid is required to operate a Medicaid Fraud Control Unit (MFCU) or to be granted a waiver. The MFCU investigates and prosecutes Medicaid provider fraud and patient abuse in state-funded health-care facilities.

The funding: The federal government pays 75% of the MFCU’s operating budget in the form of a federal-financial-participation match. The state pays the remaining 25%. Total federal-share spend nationwide is roughly $500 million per year.

The conditions: HHS-OIG conducts “recertification” reviews of each state’s MFCU and can recommend funding suspension or termination if the unit is not effectively prosecuting fraud or has lost the operational independence the statute requires.

What changed on May 13: The administration is invoking the full federal toolkit at once — (a) administrative deferment of federal Medicaid payments to specific states (the $1.3B CA action), (b) a nationwide 50-state audit of MFCU effectiveness, and (c) a parallel CMS moratorium on new hospice + home health Medicare provider enrollments. None of this requires new legislation.

What remains in state authority: States still decide who they prosecute and when. The federal government does not directly compel state criminal cases. What it can do is withdraw the federal subsidy that pays for the prosecution infrastructure — which is the lever Vance is now visibly cocking.

The order: CMS imposed a six-month moratorium on new Medicare hospice and home-health agency enrollments nationwide on May 13, 2026. The agency’s authority comes from its ordinary moratorium power for fraud-vulnerable provider categories.

Why hospice: HHS-OIG has flagged hospice for years as one of the highest-fraud Medicare categories — with documented “phantom patient” billing, ineligible-for-hospice enrollments, and kickback structures the IG and DOJ have prosecuted in California, Texas, Tennessee, and elsewhere.

Why home health: The Medicare home-health benefit has been an OIG improper-payment problem since the 1990s. The fraud cases include billing for visits that never happened, services for ineligible patients, and shell-company enrollments. The category routinely produces 10-figure annual improper-payment estimates in the OIG annual report.

The geographic effect: Existing hospice and home-health providers can continue billing. The moratorium pauses new enrollments, which has its sharpest effect in states like Texas and California that have absorbed disproportionate new-provider growth in those categories.

States with active MFCU prosecution records benefit: States that are already producing indictments at the level the federal program contemplates — Florida, Texas, Pennsylvania, Ohio — do not face the deferment risk and may even see redirected federal resources.

States with weak MFCU records carry the exposure: California, New York, Hawaii are named on the record. Other Democratic-run states with low indictment-to-spend ratios are inside the audit perimeter even if not named. Some Republican-run states are too — the May 13 audit is genuinely 50-state.

Beneficiaries are not the lever. Vance was careful in the announcement to specify that the deferment hits state-level Medicaid funding flows, not direct beneficiary payments to enrolled patients. The hospital, nursing-home, hospice, and home-health providers in the affected states absorb the federal reimbursement gap until the underlying fraud findings are addressed.

The legal pathway for states to push back: The deferment is administrative. Affected states can challenge the federal action in U.S. district court under the Administrative Procedure Act if they argue the agency action is arbitrary, capricious, or contrary to statute. As of publication, no such filing has been documented.